Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The nocebo effect challenges the non-medical infliximab switch in practice.
Boone NW, Liu L, Romberg-Camps MJ, Duijsens L, Houwen C, van der Kuy PHM, Janknegt R, Peeters R, Landewé RBM, Winkens B, van Bodegraven AA. Boone NW, et al. Eur J Clin Pharmacol. 2018 May;74(5):655-661. doi: 10.1007/s00228-018-2418-4. Epub 2018 Jan 24. Eur J Clin Pharmacol. 2018. PMID: 29368188 Free PMC article.
Editorial: nocebo effect and switching to biosimilars.
van Bodegraven AA, Boone NW. van Bodegraven AA, et al. Among authors: boone nw. Aliment Pharmacol Ther. 2018 Mar;47(6):850-851. doi: 10.1111/apt.14509. Aliment Pharmacol Ther. 2018. PMID: 29446141 No abstract available.
Single dose tocilizumab for COVID-19 associated cytokine storm syndrome: Less is more.
Boone NW, Moes DJAR, Ramiro S, Mostard RLM, Magro-Checa C, van Dongen CMP, Gronenschild M, van Haren E, Buijs J, de Vries A, Peeters R, Landewé RBM, Wong DR. Boone NW, et al. Br J Clin Pharmacol. 2023 Feb 15. doi: 10.1111/bcp.15690. Online ahead of print. Br J Clin Pharmacol. 2023. PMID: 36791777 Free article.
13 results